Quelle alimentation proposer aux patients présentant une stéatohépatite non-alcoolique ?
(2022) Nutrition Clinique et Métabolisme — Vol. 36, n° 1, p. 12-20 (2022)
Files
André-DumontNutClinMetab2022.pdf
Open Access - Adobe PDF
- 571.38 KB
Details
- Authors
- Abstract
- (en) [What diet can we offer to patients with non-alcoholic steatohepatitis?] Metabolic dysfunction-associated fatty liver disease (MAFLD) affects a quarter of the world’s population,some of whom will progress to a more severe form called non-alcoholic steatohepatitis (NASH). Themain factor leading to this condition is an unbalanced diet. No drug treatment is approved to date andonly dietary management can improve the histological lesions of NASH through weight loss. However,the efficacy of standard diets, patient compliance and the ability to maintain weight loss over the longterm are common difficulties. In this review, we analyze recent scientific data on different types of diet(Mediterranean diet, intermittent fasting, ketogenic diet), which can bring benefits on general and liverhealth. Drawbacks or limitations are also listed. The possible benefit of other nutritional strategies (coffeeconsumption, omega-3, polyphenols...) is discussed. The value of dietary change could be tailored to thepatient’s needs without necessarily imposing an intense weight loss.
- Affiliations
Citations
André-Dumont, S., & Lanthier, N. (2022). Quelle alimentation proposer aux patients présentant une stéatohépatite non-alcoolique ? Nutrition Clinique et Métabolisme, 36(1), 12-20. https://doi.org/10.1016/j.nupar.2021.11.001 (Original work published 2022)